Receptors, Transforming Growth Factor beta

"Receptors, Transforming Growth Factor beta" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Cell-surface proteins that bind transforming growth factor beta and trigger changes influencing the behavior of cells. Two types of transforming growth factor receptors have been recognized. They differ in affinity for different members of the transforming growth factor beta family and in cellular mechanisms of action.

Descriptor ID	D018125
MeSH Number(s)	D12.776.543.750.705.852.720 D12.776.543.750.750.400.820
Concept/Terms	Receptors, Transforming Growth Factor beta Receptors, Transforming Growth Factor beta Transforming Growth Factor beta Receptors Receptors, TGF-beta Receptors, TGF beta TGF-beta Receptor Receptor, TGF-beta TGF beta Receptor TGF-beta Receptors TGF beta Receptors Transforming Growth Factor beta Receptor

Below are MeSH descriptors whose meaning is more general than "Receptors, Transforming Growth Factor beta".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Membrane Proteins [D12.776.543]
Receptors, Cell Surface [D12.776.543.750]
Receptors, Immunologic [D12.776.543.750.705]
Receptors, Cytokine [D12.776.543.750.705.852]
Receptors, Transforming Growth Factor beta [D12.776.543.750.705.852.720]
Receptors, Peptide [D12.776.543.750.750]
Receptors, Growth Factor [D12.776.543.750.750.400]
Receptors, Transforming Growth Factor beta [D12.776.543.750.750.400.820]

Below are MeSH descriptors whose meaning is more specific than "Receptors, Transforming Growth Factor beta".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Receptors, Transforming Growth Factor beta" by people in this website by year, and whether "Receptors, Transforming Growth Factor beta" was a major or minor topic of these publications.

Bar chart showing 18 publications over 12 distinct years, with a maximum of 5 publications in 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	1	0	1
1996	0	1	1
1997	0	1	1
1999	1	0	1
2002	1	1	2
2004	0	1	1
2006	1	0	1
2009	0	1	1
2010	0	2	2
2015	0	1	1
2016	1	0	1
2017	1	4	5

Below are the most recent publications written about "Receptors, Transforming Growth Factor beta" by people in Profiles.

Igietseme JU, Omosun Y, Nagy T, Stuchlik O, Reed MS, He Q, Partin J, Joseph K, Ellerson D, George Z, Goldstein J, Eko FO, Bandea C, Pohl J, Black CM. Molecular Pathogenesis of Chlamydia Disease Complications: Epithelial-Mesenchymal Transition and Fibrosis. Infect Immun. 2018 01; 86(1).

View in: PubMed
Shoemaker RH, Forsthuber TG. Targeting "Retired Antigens" for Cancer Immunoprevention. Cancer Prev Res (Phila). 2017 11; 10(11):607-608.

View in: PubMed
Asrani K, Sood A, Torres A, Georgess D, Phatak P, Kaur H, Dubin A, Talbot CC, Elhelu L, Ewald AJ, Xiao B, Worley P, Lotan TL. mTORC1 loss impairs epidermal adhesion via TGF-?/Rho kinase activation. J Clin Invest. 2017 Nov 01; 127(11):4001-4017.

View in: PubMed
Wu Y, Tran T, Dwabe S, Sarkissyan M, Kim J, Nava M, Clayton S, Pietras R, Farias-Eisner R, Vadgama JV. A83-01 inhibits TGF-?-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells. Breast Cancer Res Treat. 2017 Jun; 163(3):449-460.

View in: PubMed
Varadaraj A, Jenkins LM, Singh P, Chanda A, Snider J, Lee NY, Amsalem-Zafran AR, Ehrlich M, Henis YI, Mythreye K. TGF-? triggers rapid fibrillogenesis via a novel T?RII-dependent fibronectin-trafficking mechanism. Mol Biol Cell. 2017 May 01; 28(9):1195-1207.

View in: PubMed
Jenkins LM, Singh P, Varadaraj A, Lee NY, Shah S, Flores HV, O'Connell K, Mythreye K. Altering the Proteoglycan State of Transforming Growth Factor ? Type III Receptor (T?RIII)/Betaglycan Modulates Canonical Wnt/?-Catenin Signaling. J Biol Chem. 2016 Dec 02; 291(49):25716-25728.

View in: PubMed
Sun Z, Schriewer J, Tang M, Marlin J, Taylor F, Shohet RV, Konorev EA. The TGF-? pathway mediates doxorubicin effects on cardiac endothelial cells. J Mol Cell Cardiol. 2016 Jan; 90:129-38.

View in: PubMed
Li X, Martinez-Ferrer M, Botta V, Uwamariya C, Banerjee J, Bhowmick NA. Epithelial Hic-5/ARA55 expression contributes to prostate tumorigenesis and castrate responsiveness. Oncogene. 2011 Jan 13; 30(2):167-77.

View in: PubMed
VanCleave TT, Moore JH, Benford ML, Brock GN, Kalbfleisch T, Baumgartner RN, Lillard JW, Kittles RA, Kidd LC. Interaction among variant vascular endothelial growth factor (VEGF) and its receptor in relation to prostate cancer risk. Prostate. 2010 Mar 01; 70(4):341-52.

View in: PubMed
Martinez-Ferrer M, Afshar-Sherif AR, Uwamariya C, de Crombrugghe B, Davidson JM, Bhowmick NA. Dermal transforming growth factor-beta responsiveness mediates wound contraction and epithelial closure. Am J Pathol. 2010 Jan; 176(1):98-107.

View in: PubMed

People

Explore

Similar Concepts

Top Journals